JAZZ Jazz Pharmaceuticals plc
Price Chart
Executive Summary
A cluster of three Jazz Pharmaceuticals insiders sold $3.32M in stock over a one-week window, including the EVP & Chief Commercial Officer ($1.63M) and a Director ($1.41M). The CEO made a non-cash gift of 600 shares. While the total sales represent only ~0.02% of market cap, the cluster includes multiple senior executives selling at similar prices, which warrants attention. No 10b5-1 pattern is evident, and the sales are not routine in size or timing.
Key Financial Metrics
Actionable Insight
The cluster of senior insider sales (CCO, Director, Legal Officer) at similar prices without a clear 10b5-1 pattern is a modest bearish signal. Monitor for upcoming earnings or pipeline updates that may have prompted these sales. The CEO's non-cash gift is neutral. Given the small absolute size relative to market cap, this is a watch item, not a trigger for immediate action.
Key Facts
- Three insiders sold a total of $3.32M in JAZZ stock over 7 days (May 28 – June 3, 2026).
- EVP & Chief Commercial Officer Pearce Samantha sold $1.63M (6.9K shares at $235.41).
- Director Cozadd Bruce C sold $1.41M (6.0K shares at $235.12).
- EVP & Chief Legal Officer Patil Neena M sold $282K (1.2K shares at $236.97).
- CEO Gala Renee D made a non-cash gift of 600 shares ($0 value).
- Total sales represent ~0.02% of JAZZ's $15.1B market cap.
- No 10b5-1 plan or regular pattern is disclosed; sales are not clearly routine.
Financial Impact
Total insider sales of $3.32M, or ~0.02% of market cap. While small relative to company size, the cluster of multiple senior executives selling at similar prices is notable.
Risk Factors
- Insider sales may signal management's view that the stock is fairly valued or that near-term catalysts are limited.
- No 10b5-1 plan disclosed increases the likelihood these were discretionary sales.
- The cluster includes the Chief Commercial Officer, whose sale could relate to commercial performance concerns.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-JAZZ-1780692166536 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
1d ago
|
DEFA14A
| $231.98 awaiting T+1 | awaiting T+1 | — | $232.04 (+0.03%) |
|
Jun 3, 2026
6d ago
|
Insider Cluster
| $239.17 $238.57 | ▲ +0.25% | ▼ −2.32% | $232.04 (+2.98%) |
|
Jun 3, 2026
6d ago
|
Insider Cluster
| $240.06 $238.57 | ▼ −0.62% | ▲ +1.98% | $232.04 (−3.34%) |
|
Jun 1, 2026
8d ago
|
144
| $226.12 $230.93 | ▲ +2.13% | ▲ +2.85% | $232.04 (+2.62%) |
|
May 29, 2026
11d ago
|
8-K
| $231.19 $226.12 | ▼ −2.19% | ▼ −2.34% | $232.04 (+0.37%) |
|
May 1, 2026
5w ago
|
144
| $202.51 $207.89 | ▲ +2.66% | ▲ +3.00% | $232.04 (+14.58%) |
|
Apr 24, 2026
6w ago
|
10-K/A
| $200.31 $203.07 | ▲ +1.38% | ▲ +1.86% | $232.04 (+15.84%) |
|
Apr 1, 2026
9w ago
|
144
| $186.73 $185.83 | ▼ −0.48% | ▼ −0.96% | $232.04 (+24.26%) |
|
Feb 27, 2026
14w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $232.04 (+22.77%) |
|
Feb 27, 2026
14w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $232.04 (+22.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access